Avricore Health (AVCRF) Free Cash Flow (2009 - 2025)

Avricore Health has disclosed Free Cash Flow across 14 years of filings, most recently posting -$297274.4 for Q3 2025.

• In Q3 2025, Free Cash Flow fell 148.65% year-over-year to -$297274.4; the TTM figure through Dec 2025 stood at -$184133.7 (down 113.6% YoY), while the FY2025 annual figure was -$502032.8, down 157.97% from the prior year.
• Free Cash Flow slipped to -$297274.4 in Q3 2025, from -$86356.5 in the prior quarter.
• Over the last five years, Free Cash Flow for AVCRF reached as high as $611087.3 in Q3 2024 and fell as low as -$1.5 million in Q4 2022.
• The 5-year median for Free Cash Flow is $56570.4 (2025), against an average of $1493.6.
• The widest YoY moves for Free Cash Flow: up 326.55% in 2022, down 284.65% in 2022.
• A 5-year view of Free Cash Flow shows it stood at -$379559.0 in 2021, then plunged by 284.65% to -$1.5 million in 2022, then surged by 129.75% to $434352.2 in 2023, then soared by 40.69% to $611087.3 in 2024, then tumbled by 148.65% to -$297274.4 in 2025.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$297274.4, -$86356.5, and $199497.2 for Q3 2025, Q2 2025, and Q1 2025 respectively.